8-K
Current Report
ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0000930413-05-001744
Shareholder rights changed
- Item 3.03 Material modification to rights of security holders
From the SEC's structured data for this filing
Loading c36076_8-k.txt…